Pfizer and BioNTech said Friday that the immune responses against Omicron BA.4/BA.5 subvariants were “substantially higher” in people who got its new bivalent booster compared with people who ...

Pfizer and its collaborator BioNTech have shown that their new COVID-19 booster does what they hoped it would, with the same safety and side effect profile as earlier shots. In a study released ...

Pfizer and its German partner, BioNTech, announced Friday that their updated coronavirus booster shot targeting the omicron variant succeeded in strengthening the body’s army of disease-fighting ...

By Sharon LaFraniere WASHINGTON — A new study by Pfizer and BioNTech suggests that their updated coronavirus booster is better than its predecessor at increasing the antibody levels of people ...

Nearly two-thirds of the people in the US who’ve gotten an updated booster – 32 million – have gotten Pfizer, compared with about 18 million Moderna shots.

Pfizer Inc.’s bivalent vaccine bolstered protective antibodies against the dominant omicron strains substantially more than its original booster in people older than 55, according to a company ...

A Pfizer Covid booster vaccination gave a fit 54-year-old chronic pain, NHS doctors found. Larry Lowe, from Omagh in Northern ...

Tuesday, Valneva SE (NASDAQ:VALN) and Pfizer Inc. (NYSE:PFE) released immunogenicity and safety data from their VLA15-221 Phase 2 study following a second booster vaccination of their Lyme disease ...

Regulators will require more data showing the shots are safe and effective for healthy adults and children, by requiring randomized, controlled trials to show benefits outweigh risks, FDA Commissioner ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...